Around 42% of Medicare Advantage plans offering prescription drug coverage in 2024 will get four or more stars, down from 51% this year and 68% in 2022, according to CMS data. The decline comes amid changes in contract performance scores and the implementation of a new deletion method for performance outliers. The star ratings benefit insurers by determining bonuses and influencing bids against higher benchmark rates.
Group-IB’s Threat Intelligence and Defence Centre Equip Undergraduates with Sophisticated Cybersecurity Technologies to Boost Threat Analysis and Enhance Cyber Resilience for Campus Start-ups
Hey there from the heart of the San Francisco Bay Area! It’s an absolute pleasure to have you back again for our chat on some
